Diagnos: Discover the Unseeable with CARA
Diagnos is rolling out their non-invasive AI health care technology to prescreen for diabetes-related blindness. This disruptive AI technology platfor …
A leader in artificial intelligence and healthcare technical services including algorithm development, data analysis, and image processing ever since 2001
Diagnos is rolling out their non-invasive AI health care technology to prescreen for diabetes-related blindness. This disruptive AI technology platform works seamlessly with current optometry equipment in a global market expected to double.
They have a product called CARA used for computer-assisted retinal analyses. What this product does is automatically analyze the retina, and it can spot damage caused by diabetes or cardiovascular issues. That said, Cara can actually save someone from going blind.
For more information on Diagnos (TSX.V: ADK) please click the request investor info button.
Latest Articles
Hot Companies
You might also like
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.
.jpg)
